Each filer's latest filing for 92790C104 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Fairmount Funds Management LLC
13D/A
|
14.0% |
5/13/2026
Event 5/11/2026
|
||
| Fairmount Funds Management LLC | 14.0% | |||
| Fairmount Healthcare Fund II GP LLC | 14.0% | |||
|
Paradigm Biocapital Advisors LP
13G/A
|
7.3% |
11/16/2026
Event 9/30/2026
|
||
| Paradigm BioCapital Advisors LP | 7.3% | |||
| Paradigm BioCapital Advisors GP LLC | 7.3% | |||
| Senai Asefaw, M.D. | 7.3% | |||
| Paradigm BioCapital International Fund Ltd. | 6.4% | |||
|
Bellevue Group AG
13G
|
6.6% |
5/15/2026
Event 3/31/2026
|
||
| Bellevue Group AG | 6.6% | |||
| Bellevue Asset Management AG | 6.6% | |||
|
Kynam Capital Management, LP
13G/A
|
5.7% |
8/14/2026
Event 6/30/2026
|
||
| Kynam Capital Management, LP | 5.7% | |||
| Kynam Capital Management GP, LLC | 5.7% | |||
| Yue Tang | 5.7% | |||
|
Point72 Asset Management, L.P.
13G
|
5.0% |
8/20/2026
Event 8/19/2026
|
||
| Point72 Asset Management, L.P. | 5.0% | |||
| Point72 Capital Advisors, Inc. | 5.0% | |||
| Steven A. Cohen | 5.0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (6) | ||||
| Price T Rowe Associates Inc /MD/ 13G/A | 4.5% |
11/16/2026
Event 9/30/2026
|
||
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
|
4.5% |
2/14/2025
Event 12/31/2024
|
||
| Venrock Healthcare Capital Partners III, L.P. | 4.5% | |||
| VHCP Co-Investment Holdings III, LLC | 4.5% | |||
| Venrock Healthcare Capital Partners EG, L.P. | 4.5% | |||
| VHCP Management III, LLC | 4.5% | |||
| VHCP Management EG, LLC | 4.5% | |||
| Nimish Shah | 4.5% | |||
| Bong Y Koh | 4.5% | |||
| State Street Corp 13G | 4.3% |
11/10/2026
Event 9/30/2026
|
||
|
Commodore Capital LP
13G/A
|
3.9% |
11/14/2025
Event 9/30/2025
|
||
| Commodore Capital LP | 3.9% | |||
| Commodore Capital Master LP | 3.9% | |||
|
Deep Track Capital, LP
13G/A
|
3.3% |
8/14/2026
Event 6/30/2026
|
||
| Deep Track Capital, LP | 3.3% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 3.3% | |||
| David Kroin | 3.3% | |||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 236 | 137 M | $2.83B |
| 2026 Q2 | 220 | 136 M | $2.50B |
| 2026 Q1 | 228 | 112 M | $2.21B |
| 2025 Q4 | 231 | 108 M | $3.36B |
| 2025 Q3 | 170 | 93.2 M | $2.01B |
| 2025 Q2 | 174 | 94.6 M | $1.32B |
| 2025 Q1 | 180 | 91.4 M | $1.23B |
| 2024 Q4 | 182 | 91.0 M | $1.75B |
| 2024 Q3 | 170 | 87.0 M | $1.98B |
| 2024 Q2 | 143 | 69.7 M | $906M |
| 2024 Q1 | 141 | 71.0 M | $1.24B |
| 2023 Q4 | 136 | 60.2 M | $1.31B |
| 2023 Q3 | 125 | 50.2 M | $770M |
| 2023 Q2 | 134 | 47.1 M | $1.12B |
| 2023 Q1 | 140 | 43.1 M | $1.10B |
| 2022 Q4 | 125 | 41.3 M | $1.21B |
| 2022 Q3 | 106 | 38.0 M | $778M |
| 2022 Q2 | 90 | 28.3 M | $328M |
| 2022 Q1 | 76 | 24.9 M | $461M |
| 2021 Q4 | 59 | 23.3 M | $460M |
| 2021 Q3 | 43 | 13.6 M | $224M |
| 2021 Q2 | 27 | 6.00 M | $110M |
| 2021 Q1 | 34 | 5.54 M | $84.5M |
| 2020 Q4 | 2 | 229 k | $3.77M |